William P. Quinn
Willie Quinn joined Sunesis in 2017 as Chief Financial Officer and Senior Vice President, Finance and Corporate Development. From 2011 to 2017, he served as President and CEO of Bullet Bio, a company he co-founded to develop cancer immunotherapies based on Stanford technology. Prior to that, Willie was one of the first employees at Jazz Pharmaceuticals, where he worked for more than 8 years. As head of Corporate Development his role included strategy development and execution, helping Jazz transform from a raw startup to a public, profitable specialty pharma company. Before Jazz, Willie was CFO and COO at Novation Biosciences, a biotech software company acquired by Agilent Technologies. He serves as a Director for two private companies (Midnight Pharmaceuticals and Solar Roof Dynamics) and for A Foundation Building Strength, a patient-centric non-profit finding treatments for Nemaline Myopathy. Mr. Quinn earned an MA, and a BA from Stanford University and an M.B.A. from the Stanford Graduate School of Business.